Resistant orbital pseudotumor treated with rituximab in a patient with systemic lupus erythematosus. A case presentation

Serop, 1994, Orbital myositis secondary to systemic lupus erythematosus, Acta Ophthalmol (Copenh), 72, 520, 10.1111/j.1755-3768.1994.tb02807.x Bankhurst, 1984, Exophthalmos in systemic lupus erythematosus, Ann Ophthalmol, 6, 669 Siebert, 2004, Proptosis can be the presenting feature of systemic lupus erythematosus, Ann Rheum Dis, 63, 908, 10.1136/ard.2004.020602 Jordan, 1993, Orbital panniculitis as the initial manifestation of systemic lupus erythematosus, Ophthal Plast Reconstr Surg, 9, 71, 10.1097/00002341-199303000-00012 Grimson, 1983, Orbital inflammation, myositis, and systemic lupus erythematosus, Arch Ophthalmol, 101, 736, 10.1001/archopht.1983.01040010736006 Feinfield, 1991, Orbital inflammatory disease associated with systemic lupus erythematosus, South Med J, 84, 98, 10.1097/00007611-199101000-00023 Wildinson, 1975, Exophthalmos associated with systemic lupus erythematosus, Arthritis Rheum, 18, 188, 10.1002/art.1780180222 Snebold, 1997, Orbytal pseudotumor syndromes, Curr Opin Ophthalmol, 8, 41, 10.1097/00055735-199712000-00007 Gordon, 2003, Diagnostic dilemmas in orbital inflammatory disease, Ocul Immunol Inflamm, 11, 3, 10.1076/ocii.11.1.3.15577 Gray, 1989, Recurrent acute proptosis in atypical systemic lupus erythematosus, Clin Rheumatol, 8, 528, 10.1007/BF02032109 Miquel, 2008, Successful treatment of idiopathic orbital inflammation with infliximab: an alternative to conventional steroid-sparing agents, Ophthal Plast Reconstr Surg, 24, 415, 10.1097/IOP.0b013e318182a522 Kapadia, 2006, The emerging use of TNF-alpha inhibitors in orbital inflammatory disease, Int Ophthalmol Clin, 46, 165, 10.1097/00004397-200604620-00014 Schafranski, 2009, Idiopathic orbital inflammatory disease successfully treated with Rituximab, Clin Rheumatol, 28, 225, 10.1007/s10067-008-1040-8 Salvi, 2007, Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: An open study, Eur J Endocrinol, 156, 33, 10.1530/eje.1.02325 Salvi, 2008, New immunomodulators in the treatment of Graves’ ophthalmopathy, Ann Endocrinol (Paris), 69, 153, 10.1016/j.ando.2008.02.013 Sfikakis, 2005, Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future, Curr Opin Rheumatol, 17, 550, 10.1097/01.bor.0000172798.26249.fc Melander, 2009, Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome, Clin J Am Soc Nephrol, 4, 579, 10.2215/CJN.04030808 Yan, 2004, The differentiation of idiopathic inflammatory pseudotumor from lymphoid tumors of orbit: analysis of 319 cases, Orbit, 23, 245, 10.1080/01676830490487980